References
Health Care Worker Training on the Introduction of Dolutegravir for the Treatment of HIV Infection. New York: ICAP at Columbia University; 2018. Philippines TLD/DTG TRANSITION Operational Plan. Department of Health, Republic of the Philippines; 2020. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516-523. doi:10.1016/S14733099(08)70184-1. Walkty A, Smith D, Lopko B, Kasper K. Severe skin rash associated with atazanavir. Can J Infect Dis Med Microbiol. 2009;20(1):e10-e12. doi:10.1155/2009/721956.
National HIV, AIDS, STI Prevention and Control Program: Job Aids on Dolutegravir Transition
13
